Published in AIDS Res Hum Retroviruses on January 20, 1996
Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J (2003) 2.02
Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proc Natl Acad Sci U S A (1997) 1.49
In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A (2001) 1.40
C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med (1997) 1.24
Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation. J Virol (2003) 1.15
Quantitative molecular analysis of virus expression and replication. J Clin Microbiol (2000) 1.11
Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2. Clin Exp Immunol (2001) 0.99
Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. J Clin Invest (1997) 0.91
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (1992) 3.48
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem (2000) 2.98
Start sites of bidirectional DNA synthesis at the human lamin B2 origin. Science (2000) 2.72
HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci U S A (1998) 2.12
Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol (2008) 2.07
Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89
Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res (1998) 1.86
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol (1992) 1.85
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol (1992) 1.80
E2F family members are differentially regulated by reversible acetylation. J Biol Chem (2000) 1.77
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
The gene for a novel human lamin maps at a highly transcribed locus of chromosome 19 which replicates at the onset of S-phase. Mol Cell Biol (1992) 1.66
Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples. J Clin Microbiol (1993) 1.48
High-resolution mapping of the origin of DNA replication in the hamster dihydrofolate reductase gene domain by competitive PCR. Mol Cell Biol (1996) 1.44
In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol (1993) 1.39
Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life (2001) 1.37
Cell cycle modulation of protein-DNA interactions at a human replication origin. EMBO J (1998) 1.32
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J Biol Chem (1997) 1.32
Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart (1997) 1.30
Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J Virol (2001) 1.29
In vivo protein-DNA interactions at human DNA replication origin. Proc Natl Acad Sci U S A (1996) 1.27
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J Med Virol (1991) 1.26
C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med (1997) 1.24
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet (1996) 1.21
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia (2003) 1.21
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest (1996) 1.20
A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics (1996) 1.20
A human DNA replication origin: localization and transcriptional characterization. Chromosoma (1992) 1.19
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem (1994) 1.16
Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. J Biol Chem (1999) 1.13
Replication origins of mammalian chromosomes: the happy few. Front Biosci (1999) 1.13
Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle. Gene Ther (2011) 1.12
Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J Biol Chem (2001) 1.10
Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J Virol (1996) 1.10
Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am J Hum Genet (1995) 1.09
Measles outbreak linked to an international dog show in Slovenia - primary cases and chains of transmission identified in Italy, November to December 2014. Euro Surveill (2015) 1.07
Characterization of human DNA sequences synthesized at the onset of S-phase. Nucleic Acids Res (1987) 1.07
Transcription and polyadenylation in a short human intergenic region. Nucleic Acids Res (1997) 1.06
Utilization of the same DNA replication origin by human cells of different derivation. Nucleic Acids Res (1996) 1.05
Interactions of USF and Ku antigen with a human DNA region containing a replication origin. Nucleic Acids Res (1993) 1.05
Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting. J Virol (1992) 1.03
Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther (2002) 1.02
Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1. J Virol (1995) 1.02
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J Biol Chem (1998) 1.01
Coherent dynamics of photoexcited green fluorescent proteins. Phys Rev Lett (2001) 1.00
Purification of BrdUrd-substituted DNA by immunoaffinity chromatography with anti-BrdUrd antibodies. Biotechniques (1992) 1.00
A rapid procedure for the quantitation of low abundance RNAs by competitive reverse transcription-polymerase chain reaction. Nucleic Acids Res (1994) 1.00
Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2. Clin Exp Immunol (2001) 0.99
A rapid method for immunotitration of influenza viruses using flow cytometry. J Virol Methods (2003) 0.99
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. Eur J Epidemiol (1987) 0.98
Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology (1999) 0.98
Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects. J Clin Invest (1997) 0.97
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem (2001) 0.97
Presence of transcription signals in two putative DNA replication origins of human cells. Biochim Biophys Acta (1988) 0.96
Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. Clin Chem (1995) 0.95
Stimulation of the adenovirus major late promoter in vitro by transcription factor USF is enhanced by the adenovirus DNA binding protein. J Virol (1994) 0.94
Variegation of retroviral vector gene expression in myeloid cells. Gene Ther (2000) 0.92
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin Pathol (2006) 0.92
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. AIDS (1999) 0.92
Searching for replication origins in mammalian DNA. Gene (1993) 0.91
Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. J Clin Invest (1997) 0.91
Functional properties of the separate subunits of human DNA helicase II/Ku autoantigen. J Biol Chem (1997) 0.90
Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300. J Virol (2000) 0.90
Genetic determinants of ethanol-induced liver damage. Mol Med (2001) 0.90
Selection of homeotic proteins for binding to a human DNA replication origin. J Mol Biol (2000) 0.89
DNA loop anchorage region colocalizes with the replication origin located downstream to the human gene encoding lamin B2. J Cell Biochem (1998) 0.89
The quest for a human ori. Genetica (1994) 0.87
Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. J Hepatol (1995) 0.87
Familial dilated cardiomyopathy. Br Heart J (1994) 0.86
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J Virol (2000) 0.86
Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. J Virol Methods (1991) 0.86
Inhibition of heterologous DNA replication by the MVMp nonstructural NS-1 protein: identification of a target sequence. Virology (1993) 0.85
Chromatin control of HIV-1 gene expression. Genetica (1999) 0.85
Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology (1998) 0.85
A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE. J Virol (1997) 0.84
The enhanced green fluorescent protein as a tool for the analysis of protein dynamics and localization: local fluorescence study at the single-molecule level. Photochem Photobiol (2000) 0.84
Risk factors for alcoholic liver disease. Addict Biol (2000) 0.83
Hydroxyurea treatment in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.83
Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro. AIDS Res Hum Retroviruses (1996) 0.83
Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree. J Med Genet (1994) 0.82
Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination. Scand J Immunol (2008) 0.82
Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.82
Molecular genetics of dilated cardiomyopathy. Curr Opin Cardiol (1997) 0.82
Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma. Eur J Cancer (1998) 0.81
Ticks and Lyme borreliosis in an alpine area in northeast Italy. Med Vet Entomol (2010) 0.81
Dynamics of provirus load and lymphocyte subsets after interleukin 2 treatment in HIV-infected patients. AIDS Res Hum Retroviruses (1999) 0.81
Rapid retrovirus titration using competitive polymerase chain reaction. Gene Ther (1996) 0.81
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy. Eur J Epidemiol (2003) 0.81
Effect of vascular endothelial growth factor gene therapy on post-traumatic peripheral nerve regeneration and denervation-related muscle atrophy. Gene Ther (2013) 0.81
Quantitative assessment of integrated and episomal HIV DNA. AIDS Res Hum Retroviruses (2000) 0.81
Three-year (1999-2002) of epidemiological and virological surveillance of influenza in north-east Italy. Eur J Epidemiol (2004) 0.81
HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. AIDS (1998) 0.80
V3 loop core region serotyping of HIV-1 infected patients using the FHV epitope presenting system. J Virol Methods (1997) 0.80
In vitro selection of HIV-1 TAR variants by the Tat protein. J Biotechnol (1998) 0.80
Evaluation of nutritional status in head and neck radio-treated patients affected by oral mucositis: efficacy of class IV laser therapy. Support Care Cancer (2014) 0.80